+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
PTC Therapeutics - logo

PTC Therapeutics is a biopharmaceutical company that focuses on the development and commercialization of orally administered, small molecule drugs that target post-transcriptional control processes. The company's lead product candidate is Translarna (ataluren), which is for the treatment of of nonsense mutation Duchenne muscular dystrophy in ambulatory patients. It is currently in Phase III clinical trials to treat cystic fibrosis caused by nonsense mutations. The company was founded in 1998 and is headquartered in South Plainfield, New Jersey.

Ataxia - Pipeline Insight, 2024 - Product Thumbnail Image

Ataxia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 120 Pages
  • Global
From
Huntington's Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Huntington's Disease - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 150 Pages
  • Global
From
From
From
Duchenne Muscular Dystrophy Disease - Global Clinical Trials Review, H2, 2020 - Product Thumbnail Image

Duchenne Muscular Dystrophy Disease - Global Clinical Trials Review, H2, 2020

  • Clinical Trials
  • October 2020
  • 211 Pages
  • Global
From
Amyotrophic Lateral Sclerosis - Pipeline Insight, 2024 - Product Thumbnail Image

Amyotrophic Lateral Sclerosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 250 Pages
  • Global
From
Friedreich Ataxia - Pipeline Insight, 2024 - Product Thumbnail Image

Friedreich Ataxia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Drug Resistant Epilepsy - Pipeline Insight, 2024 - Product Thumbnail Image

Drug Resistant Epilepsy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Rett Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Rett Syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • February 2024
  • 60 Pages
  • Global
From
Spinal Muscular Atrophy (SMA) Global Clinical Trials Review, H1, 2020 - Product Thumbnail Image

Spinal Muscular Atrophy (SMA) Global Clinical Trials Review, H1, 2020

  • Clinical Trials
  • February 2020
  • 105 Pages
  • Global
From
Leiomyosarcoma - Pipeline Insight, 2024 - Product Thumbnail Image

Leiomyosarcoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Leigh disease - Pipeline Insight, 2024 - Product Thumbnail Image

Leigh disease - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Loading Indicator